Addiction
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) |
HHS-NIH11 |
10/04/2023 |
03/19/2025 | |
|
NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed) |
HHS-NIH11 |
09/20/2023 |
01/24/2024 | |
|
NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed) |
HHS-NIH11 |
09/20/2023 |
01/24/2024 | |
|
Grants to Support New Investigators in Conducting Research Related to Understanding Drug Use and Overdose Risk and Protective Factors (K01) |
HHS-CDC-HHSCDCERA |
08/30/2023 |
12/01/2023 | |
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
HHS-NIH11 |
08/24/2023 |
10/30/2026 | |
|
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
07/19/2023 |
02/01/2024 | |
|
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) |
HHS-NIH11 |
07/19/2023 |
02/01/2024 | |
|
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) |
HHS-NIH11 |
07/19/2023 |
03/19/2025 | |
|
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) |
HHS-NIH11 |
07/19/2023 |
03/19/2025 | |
|
HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) |
HHS-NIH11 |
06/08/2023 |
10/18/2023 | |
|
HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) |
HHS-NIH11 |
06/08/2023 |
10/18/2023 | |
|
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
05/16/2023 |
11/02/2023 | |
|
Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required) |
HHS-NIH11 |
05/16/2023 |
11/02/2023 | |
|
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required) |
HHS-NIH11 |
05/16/2023 |
11/02/2023 | |
|
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed) |
HHS-NIH11 |
05/02/2023 |
11/09/2023 | |
|
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) |
HHS-NIH11 |
04/27/2023 |
06/09/2025 | |
|
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) |
HHS-NIH11 |
01/12/2023 |
11/18/2025 | |
|
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) |
HHS-NIH11 |
12/28/2022 |
11/17/2025 | |
|
HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain(R01 Clinical Trial Not Allowed) |
HHS-NIH11 |
08/09/2022 |
03/06/2024 | |
|
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) |
HHS-NIH11 |
08/09/2022 |
11/14/2024 | |
|
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) |
HHS-NIH11 |
08/09/2022 |
11/14/2024 | |
|
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) |
HHS-NIH11 |
08/01/2022 |
06/09/2025 | |
|
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) |
HHS-NIH11 |
07/14/2022 |
11/12/2025 | |
|
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) |
HHS-NIH11 |
07/14/2022 |
11/12/2025 | |
|
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
HHS-NIH11 |
05/09/2022 |
03/21/2025 | |
|
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
HHS-NIH11 |
05/09/2022 |
03/21/2025 | |
|
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) |
HHS-NIH11 |
03/14/2022 |
11/15/2024 | |
|
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
HHS-NIH11 |
09/02/2021 |
09/08/2024 | |
|
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
HHS-NIH11 |
03/26/2021 |
03/08/2024 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) |
HHS-NIH11 |
11/16/2020 |
11/15/2023 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) |
HHS-NIH11 |
11/16/2020 |
11/15/2023 |
|
|
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) |
HHS-NIH11 |
10/27/2020 |
11/15/2023 |
|
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
HHS-NIH11 |
09/29/2020 |
10/31/2023 |